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Effects of Circulating and Local Uteroplacental
Angiotensin II in Rat Pregnancy
Lydia Hering, Florian Herse, Nele Geusens, Stefan Verlohren, Katrin Wenzel, Anne C. Staff,
K. Bridget Brosnihan, Berthold Huppertz, Friedrich C. Luft, Dominik N. Muller, Robert Pijnenborg,
Judith E. Cartwright, Ralf Dechend
Abstract—The renin-angiotensin (Ang) system is important during placental development. Dysregulation of the renin-Ang
system is important in preeclampsia (PE). Female rats transgenic for the human angiotensinogen gene crossed with
males transgenic for the human renin gene develop the PE syndrome, whereas those of the opposite cross do not. We
used this model to study the role of Ang II in trophoblast invasion, which is shallow in human PE but deeper in this
model. We investigated the following groups: PE rats, opposite-cross rats, Ang II–infused rats (1000 ng/kg per day), and
control rats. Ang II infusion increased only circulating Ang II levels (267.82 pg/mL), opposite cross influenced only
uteroplacental Ang II (13.52 fmol/mg of protein), and PE increased both circulating (251.09 pg/mL) and uteroplacental
(19.24 fmol/mg of protein) Ang II. Blood pressure and albuminuria occurred in the models with high circulating Ang
II but not in the other models. Trophoblast invasion increased in PE and opposite-cross rats but not in Ang II–infused
rats. Correspondingly, uterine artery resistance index increased in Ang II–infused rats but decreased in PE rats. We then
studied human trophoblasts and villous explants from first-trimester pregnancies with time-lapse microscopy. Local Ang
II dose-dependently increased migration by 75%, invasion by 58%, and motility by 282%. The data suggest that local
tissue Ang II stimulates trophoblast invasion in vivo in the rat and in vitro in human cells, a hitherto fore unrecognized
function. Conceivably, upregulation of tissue Ang II in the maternal part of the placenta represents an important growth
factor for trophoblast invasion and migration. (Hypertension. 2010;56:311-318.)
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Various studies have implicated the renin-angiotensin(Ang) system in preeclampsia (PE).1–3 Female rats
harboring the human angiotensinogen gene develop hyper-
tension and proteinuria late in pregnancy when mated with
male rats harboring the human renin gene; the result is a
PE-like syndrome.4 However, instead of showing shallow
trophoblast invasion associated with PE in humans, tropho-
blast invasion and spiral artery remodeling are actually
increased in this animal model.4,5 Trophoblast invasion is
highly relevant in pregnancy. These fetal cells invade the
maternal decidua and remodel the spiral arteries, a process
that includes replacing the smooth muscle cell layer with
fibrinoid material. The remodeling of the uterine spiral
arteries causes the vessels to increase in diameter, allowing
for an increase in blood flow to the intervillous space of the
placenta.6 The role of Ang II in this process is unclear.
The hallmark of PE is a shallow trophoblast invasion
accompanied by a reduced percentage of remodeled spiral
arteries in the decidua and no remodeling in the inner
myometrium.6 Preliminary observations in our transgenic rat
model indicated that the opposite cross (OC), namely dams
harboring a human renin gene mated with males harboring
human angiotensinogen, did not develop hypertension or a
PE-like syndrome.4 In addition to the circulating renin-Ang
system, several authors have described a local, uteroplacental
renin-Ang system in pregnancy.7–10 However, the function of
the uteroplacental renin-Ang system is unknown. Consistent
with the observations in rat pregnancy, we showed earlier that
components of the tissue renin-Ang system are substantially
higher in the maternal part of the human placenta (the
decidua), than in the fetal part (placenta), suggesting a role for
local Ang II in the trophoblast-decidua interaction.11
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We investigated the effects of uteroplacental Ang II and
circulating Ang II in rat pregnancy in more detail. We studied
our conventional PE-syndrome cross, the OC, and chronic
Ang II–infused pregnant rats and appropriate control rats. We
also extended our observations to in vitro Ang II–related
effects on cells derived from human trophoblasts and villous
explants from first-trimester pregnancies. Our data show that
uteroplacental Ang II has opposite in vivo effects on tropho-
blast invasion, migration, uteroplacental vascular remodeling,
and maternal endothelial dysfunction compared with circu-
lating Ang II. Local Ang II could serve as a potent regulator
promoting trophoblast migration and invasion early in
pregnancy.
Methods
Animal Studies
Details on the TGR models (PE and OC) have been published
previously.4,12 On day 9 of gestation, Sprague-Dawley (SD) dams
were randomly assigned to 1 of 2 experimental groups: SD plus
vehicle, which served as the control group (n9) or SD plus Ang II
(n8), at a dose of 1000 ng/kg per min (Ang II). The animals were
followed to term (day 21), anesthetized, and then euthanized. Doppler
studies were performed as described earlier.13 Peak systolic velocity
(PSV) and end-diastolic velocity (EDV) were measured from 3 cardiac
cycles. The resistance index (RI[PSVEDV]/PSV) was calculated
when EDV was 0 to quantify the pulsatile arterial blood velocity
waveforms.
Tissue sections were immediately snap frozen in liquid nitrogen
and homogenized as described previously.4,11,13 Tissue Ang II and
circulating Ang II were measured by radioimmunoassay.7 Tissue
preparations and immunostaining protocols were performed as de-
scribed earlier.5,14 For the quantitative analysis of depth of invasion
and spiral artery remodeling, the KS-400 image analysis system
(Carl Zeiss) was used, and the length of each traced line was
measured and calculated in relation to spiral artery lumen contour.
More detailed information is given in the online Data Supplement
(please see http://hyper.ahajournals.org).
Cell Culture
SGHPL-4 cells (derived from primary human first-trimester extra-
villous trophoblasts transfected with the early region of SV40,
known previously as MC418) were cultured as described earlier.15
The effect of 48-hour Ang II stimulation in matrigel on the invasive
trophoblast outgrowth was investigated as described earlier.16 Hu-
man placental villous tissue explants from first-trimester pregnancies
were established and characterized as described previously.17 Migra-
tion experiments were conducted with collagen-coated chambers
after 72-hour Ang II exposure. More detailed information is given in
the online Data Supplement.
Statistics
Data are presented as meanSEM. We tested Kolmogorov-Smirnov
for distribution. For group differences we tested 1-way ANOVA
with Bonferroni post hoc test, Dunnett T3, or Kruskal-Wallis test and
Mann-Whitney U test, as appropriate. A value of P0.05 was
considered statistically significant.
Results
Circulating and Local Uteroplacental Ang II
Circulating Ang II was increased in PE rats and in rats after
Ang II infusion (Figure 1A). OC rats had similar plasma Ang
II levels as SD. In contrast to the circulating plasma, local
uteroplacental tissue concentration of Ang II was increased in
both PE and OC rats (Figure 1B). Ang II infusion did not lead
to an increase in uteroplacental Ang II. Thus, PE is a rat
model with high uteroplacental and circulating Ang II levels.
OC results in solely high uteroplacental Ang II values at term
and normal circulating values. Human renin and angio-
tensinogen (hAogen) mRNA expressions were significantly
elevated in the OC and PE uteroplacental units and were
undetectable in SD and Ang II (Figure S1, available in the
online Data Supplement). hAogen expression was signifi-
cantly higher in PE compared with OC, especially in the
mesometrial triangle. Ang II infusion raised the circulating
Ang II values but not the uteroplacental Ang II
concentrations.
Blood Pressure, Albuminuria, and Intrauterine
Growth Retardation
Telemetric blood pressure measurements showed that mean
arterial blood pressure significantly increased PE and Ang II
and decreased in OC in the last third of pregnancy. Blood
pressure was significantly increased in PE and Ang II
compared with SD. Mean arterial blood pressure was signif-
icantly decreased in OC versus control (Figure 2A). Albu-
minuria was present in PE and Ang II–infused rats, but not in
OC or SD rats, in the last third of pregnancy (Figure 2B).
Placental weight was lower in PE and Ang II–infused rats.
OC rats had placental weights no different from SD rats
(Figure 2C, left). Fetal body weight was reduced in PE, OC,
and Ang II–infused rats (Figure 2C, middle). To further
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Figure 1. A, Circulating Ang II levels on days 9, 15, and 21 of
pregnancy. These values were highest in PE rats. Ang II–infused
rats had correspondingly elevated values. OC rats had values
no different from SD rats. B, Ang II levels in the uteroplacental
unit on days 9, 15, and 21 of pregnancy. PE and OC placentas
had increased values on day 21. Ang II infusion placentas had
lower values, similar to SD. Values are meanSEM. *P0.05 vs
SD; †P0.05 vs OC.
312 Hypertension August 2010
 at SWETS SUBS SERV-#52115135 on March 8, 2013http://hyper.ahajournals.org/Downloaded from 
characterize intrauterine growth retardation (IUGR), we in-
vestigated the brain:liver ratio in the fetuses. In PE and Ang
II–infused rats, we found a reduced liver and preserved brain
weight, leading to an increased brain:liver ratio consistent
with IUGR (Figure 2C, right). The OC rats had a normal
brain:liver weight ratio and a normal placenta weight, so that
the criteria for IUGR were not fulfilled, although these rats
had pups small for gestational age compared with SD rats.
These data indicate that PE-like features and IUGR were only
present in the groups with high circulating Ang II levels.
However, slow fetal growth without signs of IUGR took
place when uteroplacental Ang II was elevated, even with
normal circulating Ang II levels.
Trophoblast Invasion and Spiral Artery
Vascular Remodeling
Endovascular trophoblast invasion was evaluated in the
mesometrial triangle in 3 zones according to the immunohis-
tograph picture, which was stained with cytokeratin 7 to
identify trophoblasts (Figure 3A, left) and as described
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Figure 2. A, Telemetrically measured mean arterial blood pressures. PE rats and Ang II–infused rats showed a significantly increased
blood pressure over time, whereas mean arterial pressure within OC rats significantly decreased toward the end of pregnancy
(*P0.05). Analyzing the different groups among each other, mean arterial blood pressure was significant for PE, Ang II, and OC vs SD
controls (†P0.05). The arrow with plug indicates the observation of plug in the vagina, indicating day 1 of pregnancy. B, Albuminuria,
which occurred in PE and Ang II–infused rats (*P0.01 vs SD; †P0.01 vs OC). C, Placenta weight (left), fetal weight (middle), and
brain:liver weight ratio (right). Placental weight was reduced in PE and Ang II rats. Fetal weight was decreased in PE, Ang II, and OC
rats. Brain:liver ratio showed the difference in PE and Ang II rats, indicating IUGR in these 2 groups but not in OC rats. Values are
meanSEM (*P0.001 vs SD; †P0.001 vs OC).
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earlier.5,13,18 We showed earlier that deep endovascular tro-
phoblast invasion was significantly increased in PE and OC
rats, resulting in altered vascular remodeling of spiral arteries
(Figure 3A, right).5,13 In contrast, Ang II infusion resulted in
a reduced deep-trophoblast invasion in the mesometrial tri-
angle compared with SD controls (Figure 3B, left). Examples
of reduced trophoblast invasion by Ang II infusion compared
with SD are shown (Figure 3B, right). In accord with
alterations in trophoblast invasion, persistence of vascular
smooth muscle cells (VSMC) was increased in Ang II–
infused compared with SD controls (Figure 3C). We mea-
sured the functional consequences of the altered trophoblast
and VSMC expression by B-mode Doppler ultrasound (Fig-
ure 3D). The measurements showed increased resistance
index with Ang II infusion compared with SD controls,
indicating that placental blood flow had decreased. We found
a decrease in the resistance index in PE rats and OC rats,
consistent with our earlier report.13
Invasion, Migration, and Motility of Trophoblasts
We next investigated human trophoblasts from fist-trimester
pregnancies to determine the effect of uteroplacental Ang II.
We stimulated SGHPL-4 cells, which were derived from
primary human first-trimester extravillous trophoblasts. The
cells were treated with 2 concentrations of Ang II and were
studied with time-lapse microscopy (Figure 4A). Ang II
dose-dependently increased the various aspects of invasion
(showing more and deeper invasion) and motility. The effects
of Ang II were blocked completely with losartan. To deter-
mine whether Ang II has an effect on the migration, villous
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Figure 3. A, A rat placenta with associ-
ated mesometrial triangle stained with
cytokeratin 7, identifying trophoblasts.
Trophoblast invasion in the mesometrial
triangle was evaluated in 3 depth levels
from the central spiral artery to the
periphery (left). Invasion was determined
in terms of percentage trophoblast/ves-
sel contour.18 As described earlier, tro-
phoblast invasion was more intense and
deeper in PE rat placentas, as shown by
the trophoblast/vessel contour (repro-
duced with permission from Geusens et
al,14 copyright Elsevier 2010). OC rat pla-
centas showed a significantly higher per-
centage of endovascular trophoblast/
contour indicating more deep
trophoblast invasion than SD (right). B,
Reduced trophoblast invasion in Ang
II–infused rats compared with controls
(left). The invasion actually decreased.
Right is shown a representative immuno-
histochemistry picture for trophoblast
staining verifying reduced trophoblast
invasion in Ang II–infused rats. Cell num-
ber of trophoblasts is lower in Ang II–in-
fused compared with SD placenta, con-
firming this result. C, Increased
persistence of VSMCs in the spiral arter-
ies in Ang II–infused rats, indicating
reduced vascular remodeling, confirming
B. D, Doppler ultrasound of the uterine
arteries. Resistance index was increased
in Ang II–infused rats on day 21 of ges-
tation compared with controls. OC and
PE rats show reduced resistance index.
Values are meanSEM (*P0.05 vs SD).
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explants from first-trimester normal pregnancies were used
for in vitro invasion assay experiments in collagen-coated
chambers (Figure 4B). Ang II for 72 hours resulted in a strong
increase in the migration of extravillous trophoblasts cells
compared with control cells. These results were reproducible
in 3 separate experiments.
Discussion
The novel finding in our study was that circulating Ang II
reduced trophoblast invasion and vascular remodeling in the
uteroplacental unit. We found opposite effects of increased
circulating and uteroplacental Ang II in pregnant rats. Ang
II–infused rats exhibited an increased blood pressure in the
third trimester, albuminuria, and IUGR. The OC model, in
which only uteroplacental tissue Ang II is increased, showed
increased trophoblast remodeling. Blood pressure was lower
than in controls, no albuminuria was present, and pup weights
were reduced. In the PE cross, in which circulating and tissue
Ang II are increased, we observed hypertension in the last
trimester, albuminuria, IUGR, increased trophoblast invasion,
and uteroplacental vascular remodeling. Finally, by applying
Ang II directly to human first-trimester trophoblasts and
villous explants, we found that invasion, migration, and
motility were increased in response to local Ang II. We
believe that our results show a different and unique function
for uteroplacental Ang II in pregnancy. Uteroplacental Ang II
but not circulating Ang II increased trophoblast invasion and
vascular remodeling.
Several studies have shown the presence of a local
tissue-specific renin-Ang system in the uteroplacental unit
of normal pregnancies.2,7–10 Estrogen increases both tissue
and circulating levels of angiotensinogen and renin.7
Plasma Ang II, together with angiotensinogen and plasma
renin activity, is increased during normal pregnancy.19
However, the physiological function of a stimulated utero-
placental renin-Ang system during pregnancy is unknown.
Our results of an increased trophoblast invasion by tissue
Ang II are in line with the human results that we reported
earlier in that increased renin, angiotensinogen, Ang-
converting enzyme (ACE), and Ang II are substantially
increased in the maternal part of the uteroplacental unit,
the deciduas, compared with the fetal part of the plac-
enta.11 We now suggest that the maternal-fetal Ang II
gradient contributes to trophoblast invasion and migration.
Rosenfeld and Gant20 reported that Ang II infusion in-
creased blood pressure in sheep but reduced uteroplacental
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Figure 4. SGHPL-4 cells, which were derived from primary human first-trimester extravillous trophoblasts, were exposed to 2 different
Ang II concentrations, and time-lapse microscopy was performed. A, A representative result from the time-lapse microscopy under
control (left) and Ang II stimulation (right), and average results is showing that Ang II affects the invasive process, invasion length, and
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perfusion, which was measured invasively with chroni-
cally implanted flow probes around both major uterine
arteries. Their experiments suggested an autoregulation of
uterine blood flow. Earlier, Ferris et al21 showed that an
increase of uterine renin production resulted in an increase
in uterine perfusion in rabbits. Uterine perfusion was
determined with radioactive microspheres lodged in the
uterus and placenta after injection in the left ventricle in
that study. Li et al22 were the first to show that endocrine-
active decidual cells express both renin and angioten-
sinogen in the human uteroplacental unit. They suggested
that decidual cells regulate a tissue renin-Ang system
expression in the endometrium. Anton and Brosnihan7
were the first to suggest a different regulation for circu-
lating and uteroplacental Ang II in PE. They observed
contrasting changes for Ang II levels in the circulation and
chorionic villi in human preeclamptic pregnancy. Al-
though circulating Ang II was significantly decreased, the
expression of local tissue Ang II was augmented in the
placenta of the preeclamptic women. Uteroplacental Ang II
in the OC and PE groups was elevated because the
expression of both human renin gene and hAogen mRNA
in the uteroplacental unit was increased. hAogen was
significantly higher in PE, indicating that hAogen concen-
trations were responsible for the different Ang II levels in
OC and PE rats.23 Morgan et al24 were able to show
increased expression of an angiotensinogen variant in
human decidual spiral arteries that are involved in the
generation of atherotic (a histopathologic term applied to
PE-related vascular changes resembling atherosclerosis)
lesions overrepresented in PE.
Trophoblast cells of the human placenta proliferate, mi-
grate, and invade the pregnant uterus and remodel its vascu-
lature. Trophoblast-associated spiral artery remodeling is an
important uterine adaptation mechanism of human preg-
nancy, allowing an adequate maternal blood supply to the
placenta. Few factors have been shown to promote tropho-
blast invasion and survival of these fetus-derived cells in the
maternal surroundings, including corticotropin-releasing hor-
mone, insulin-like growth factor binding protein 1, and
various cytokines, such as interleukin 1.25 The role of many
growth factors and proto-oncogenes has not yet been thor-
oughly studied in the decidua.
We found that fetal weight was decreased in the Ang
II–infused group compared with controls. Similar to patients
with PE, we observed a shallow trophoblast invasion, as well
as persistence of VSMCs and reduced spiral artery remodel-
ing in the group with chronic Ang II infusion. The increased
resistance indicates a disturbed placental function with re-
duced transformation of the arterioles into a highly dilated
vessel. In accordance with the human pathology in PE, the
increased vascular resistance led to IUGR and decreased birth
weight in this group. The pathophysiological processes un-
derlying IUGR are highly complex and incompletely under-
stood. The finding that the fetal weight was decreased in the
OC group appears surprising, because trophoblast invasion is
increased and vascular resistance decreased. The pups exhib-
ited lower birth weight, but not IUGR, suggesting a different
mechanism compared with the Ang II–infused group that did
exhibit IUGR. In earlier studies, we showed that atherosis is
present in OC, which also might contribute to impaired fetal
growth.4,5 We noted focal necrosis in the arterial wall in 25%
of spiral arteries in that study. The atherosis in these models
is similar to the acute atherosis associated with placental
infarcts observed in uteroplacental spiral arteries of pre-
eclamptic women.26 The impact of this vasculopathy on fetal
growth is unclear.6,27 Shibata et al28 showed that Ang II
suppresses Na-K-ATPase in human placental villi, consis-
tent with possible adverse effects of enhanced placental Ang
II on fetal growth. These findings are consistent with those of
our OC.
We showed that local Ang II caused human trophoblasts
to migrate and invade, similar to the trophoblast behavior
in the PE and OC models, where uteroplacental Ang II is
elevated. These data could suggest similar effects and
functional roles of local uteroplacental Ang II in our rat
model and in the decidua of pregnant women. Furthermore,
our findings could suggest that Ang II plays a central role
in signaling trophoblast invasion and, ultimately, spiral
artery remodeling. Ang II induces migration of various
cells, including dendritic cells, VSMCs, and glomerular
mesangial cells.29 The results in trophoblasts are contro-
versial. Xia et al30 found that Ang II inhibits migration of
the trophoblast cell line, HTR-8, via plasminogen activator
inhibitor 1 activation. Ishimatsu et al31 found the opposite.
They showed that direct-application Ang II induces migra-
tion in human cytotrophoblast-like choriocarcinoma cell
lines. Local Ang II also influences endothelial cadherin,
platelet-endothelial adhesion molecule 1, vascular endo-
thelial adhesion molecule 1, and 4 integrins. These
factors are important in facilitating the adhesion-pheno-
type switch in trophoblasts, which is required for success-
ful endovascular invasion and normal placentation.32
Taken together, these data suggest that local Ang II is an
important uteroplacental factor regulating the temporal and
spatial regulation of trophoblast invasion in a paracrine
way.
Circulating Ang II levels in the PE cross increased
between day 9 and day 15, exactly when we started the
Ang II infusion in the Ang II–infused group. However, a
shorter time of exposure to Ang II in the Ang II–infused
group compared with the transgenic group cannot be
excluded as a variable contributing to the observed phe-
notypes. We also excluded the possibility that proteases are
dysregulated in the Ang II–infused group. Aminopeptidase A,
Prolyl-carboxypeptidase, Neprilysin, ACE-1, and ACE-2
were not induced in the Ang II–infused group compared with
controls (data not shown). Aminopeptidase A, ACE-1, and
ACE-2 were upregulated in OC and PE compared with
control and Ang II (data not shown).
Ours and other laboratories have described activating
autoantibodies directed at the Ang II type 1 receptor in
women with human PE.3,33 We made similar observations in
PE rats.4,34 The role of these antibodies is still unclear.
However, upregulation of the decidual Ang II type 1 receptor
is also present in PE.11,35 Both events could represent a
possible physiological adaptation, suggesting the necessity of
increased Ang II–like activity in promoting trophoblast inva-
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sion for spiral artery remodeling. The antibodies could
represent malfunction of this mechanism resulting in PE in
some women.
The rodent transgenic renin/angiotensinogen model was
originally described in mice by Takimoto et al36 Hyperten-
sion, proteinuria, and IUGR described in that study were very
similar to the rat PE model that we report. However, placental
abnormalities were different in the 2 species. Takimoto et al36
detected necrosis in spongiotrophoblasts and decidual cells,
edematous enlargement, and congestion in chorion cells. In a
follow-up study, the group showed that the interaction be-
tween fetal vasculature and maternal blood canal in the
labyrinth was distorted and the expression patterns of key
molecules in neovascularization were dysregulated.37 The
maternal plasma level of sFlt-1 was significantly increased
after midterm in that model.37 In contrast to the mouse, the rat
develops deep endovascular and interstitial trophoblast inva-
sion beyond the decidua into the mesometrial triangle, show-
ing a deep endovascular trophoblast-associated spiral artery
remodeling. Thus, we can investigate the labyrinth placenta
and the mesometrial triangle separately. sFlt-1 is not dysregu-
lated in the rat placenta or in the maternal serum in PE rats.13
In spite of the species differences, both models underscore the
notion that cell-specific expression of renin and angioten-
sinogen in the fetomaternal interface strongly influences
IUGR and placenta development.
A limitation in our study is that an ACE inhibitor and/or
Ang II type 1 receptor blocker was not tested in our models.
Saito et al showed that genetic deletion of the maternal Ang
II type 1a receptor, and cross-breeding with the transgenic
mouse model significantly ameliorated the phenotype in their
mice.38 The role of Ang II inhibition on trophoblast function,
vascular remodeling in the uteroplacental unit, and IUGR
requires substantial further study in animal models, particu-
larly because human studies along these lines cannot be
performed.
Perspectives
Uteroplacental Ang II promoted trophoblast migration and
invasion in rats and humans. This effect could mediate a
cross-talk between invasive trophoblasts and the maternal
endometrium. Such a paracrine Ang II function in normal
pregnancy could also be further activated in pregnancies with
abnormal placentation that exhibit shallow trophoblast inva-
sion, as in PE. The concept of a fetal-maternal Ang II gradient
warrants further investigations, such as the determination of
Ang II in the amniotic fluid.
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Methods 
Animal studies 
Local authorities approved the studies along American Physiological Society guidelines. 
Mean blood pressure, heart rate, and ambulatory activity were continuously recorded by 
radiotelemetry (Data Sciences International). Sprague-Dawley females were mated with 
Sprague-Dawley males as controls, namely pregnant Sprague-Dawley (SD). 
For Doppler studies, the animals were anesthetized with 1.5% isoflurane via an oxygen mask. 
The pregnant rats were imaged at embryonic days 9.0, 15.0, 18.0, and 21.0 with an ultrasound 
bio-microscope and a 30-MHz or 40-MHz transducer at 30 frames per second (Model Vevo 
660, VisualSonics). The Doppler waveforms were obtained from the proximal uterine artery, 
arcuate artery, and distal of the main branch of the uterine artery between 2 embryonic 
implantation sites.  
Blood for hormone analysis was drawn by aortic puncture into pre-chilled tubes containing 
EDTA (6.25 mmol/L) and phenanthroline (26 mmol/L) as anticoagulant and inhibitor of Ang 
II breakdown in vitro, respectively. The direct renin inhibitor, aliskiren (10-6 M), was added to 
plasma samples for Ang II measurement to prevent Ang II formation in vitro 
For tissue immunostaining protocols all implantation sites (placenta with associated 
mesometrial triangle) were removed, fixed in JB-Fix fixative, and embedded into Paraplast 
Plus (Sherwood Medical Co) from each rat. Parallel sections were cut step-serially from each 
implantation site parallel to the mesometrial-fetal axis. A set containing a central maternal 
arterial channel was selected for further analysis. Parallel, serial cross-sections were obtained 
and stained for anti  -actin (clone 1A4, Dako, diluted 1/200), anti cytokeratin (clone 
MNF116, Dako), and anti CD31 (clone TLD-3A12, BDPharmingen). For the quantitative 
analysis of depth of invasion and spiral artery remodeling, the KS-400 image analysis system 
(Carl Zeiss) connected to a Zeiss microscope (Axioskop 50) fitted with a color camera 
(Axiocam MRc5) was used. Briefly, the whole mesometrial triangle was photographed and 
the images were shade-corrected. The border of the triangle was manually delineated on the 
α-actin immunostained section, and the triangle was divided into three concentric depth levels 
of equal thickness for the evaluation of the depth of invasion. The lumen of each spiral artery 
(SA) cross- section was manually delineated and stretches of endovascular trophoblast, 
fibrinoid, vascular smooth muscle and CD31 positive endothelium were traced separately 
over the lumen contour tracing. For every cross-section, the length of each traced line was 
measured and percentages of all lengths were calculated in relation to the total length of the 
spiral artery lumen contour.  
 
Cell culture 
  SGHPL-4 cells were derived from primary human first trimester extravillous 
trophoblasts (EVT) and transfected with the early region of SV40 The cells were cultured in 
Ham’s F10 medium supplemented with 10% FBS, L-glutamine (2 mM), penicillin (100 
IU/ml) and streptomycin (100 μg/ml). These cells show similar invasive capabilities to 
primary EVT and retain features of normal extravillous trophoblast, including expression of 
HLA-G, cytokeratin-7, BC-1, CD9 and human placental lactogen. Ang II stimulation (10-6 M, 
10-8 M, Calbiochem) and 10-6 M losartan (Calbiochem) were applied for 48h in 0.5% serum-
reduced medium in matrigel. The effect on the invasive trophoblast outgrowth (number of 
invasive processes, length of invasion) was assessed by phase contrast microscopy (Olympus) 
and Image Pro Plus Software (Media Cypernetics). For this purpose, the cells were grown on 
beads. Motility of SGHPL-4 cells was monitored by time-lapse microscopy (TLM) using an 
Olympus IX70 inverted fluorescence microscope with a motorized stage and cooled CCD 
camera (Hamamatsu C4742-95) enclosed in a humidified chamber at 37°C with 5% CO2 in 
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air at 15 min intervals for 6 hours as described previously. Forty cells were scored in each 
field of view.  
  Human placental villous tissue explants from first trimester pregnancies were 
established and characterized as previously described.20 Four placentas were obtained from 
healthy women after legal termination of pregnancy (5-10 weeks of gestation). Informed, 
written consent was obtained after due approval from the local institutional ethical review 
board. Briefly, the placentas were washed in sterile phosphate-buffered saline (PBS) until the 
supernatant was nearly free of blood. Areas rich in chorionic villi were selected and were 
grown on collagen-coated (Sigma) plates in DMEM/Hams F12 supplemented with 1% 
P/S/Amphotericin B and 10% human serum. Migration experiments were conducted with 
collagen coated chambers (24-well plates; BD Biosciences) according to the manufacturer’s 
instructions. The effects of Ang II images were taken after 72 h and the area of trophoblast 
outgrowth was analyzed with ImageJ software. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1. Expressionlevels of the transgenes human renin and human angiotensinogen 
(AGT) in the uteroplacental unit of the SD-, OC-, PE- and AngII-group at days 15 and 21 of 
pregnancy. (nd = not detectable) 
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